Analysts have adjusted their fair value estimate for Shree Cement slightly downwards, from ₹31,229 to ₹30,858. This revision is attributed to tempered growth projections and a marginally higher discount rate in their updated outlook.
What's in the News
- A Board Meeting is scheduled for October 28, 2025, at 15:00 IST to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30, 2025 (Key Developments).
- The agenda includes the declaration of an interim dividend of INR 80 per equity share for the financial year 2025-26 (Key Developments).
- The interim dividend will be paid to shareholders on the record date, which is set as Monday, November 3, 2025 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target: The fair value estimate has decreased slightly from ₹31,229 to ₹30,858.
- Discount Rate: The discount rate has risen marginally from 13.84% to 14.09%.
- Revenue Growth: Projected revenue growth has fallen from 8.58% to 7.91%.
- Net Profit Margin: The estimated profit margin has declined from 12.11% to 11.54%.
- Future P/E: The forward price-to-earnings ratio has moved higher, from 59.62x to 61.17x.
Have other thoughts on Shree Cement?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.